BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 30019644)

  • 21. Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives.
    Malghani Z; Khan AU; Faheem M; Danish MZ; Nadeem H; Ansari SF; Maqbool M
    Anticancer Agents Med Chem; 2020; 20(13):1516-1529. PubMed ID: 32416701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
    Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
    Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents.
    Gholap S; Tambe M; Nawale L; Sarkar D; Sangshetti J; Damale M
    Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29292534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
    Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
    Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation.
    Subhedar DD; Shaikh MH; Shingate BB; Nawale L; Sarkar D; Khedkar VM; Kalam Khan FA; Sangshetti JN
    Eur J Med Chem; 2017 Jan; 125():385-399. PubMed ID: 27688192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino Acid Conjugates of Aminothiazole and Aminopyridine as Potential Anticancer Agents: Synthesis, Molecular Docking and in vitro Evaluation.
    Naz S; Shah FA; Nadeem H; Sarwar S; Tan Z; Imran M; Ali T; Li JB; Li S
    Drug Des Devel Ther; 2021; 15():1459-1476. PubMed ID: 33833504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis.
    Chitre TS; Asgaonkar KD; Miniyar PB; Dharme AB; Arkile MA; Yeware A; Sarkar D; Khedkar VM; Jha PC
    Bioorg Med Chem Lett; 2016 May; 26(9):2224-8. PubMed ID: 27017114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico Studies, Synthesis and Antitubercular Activity of Some Novel Quinoline - Azitidinone Derivatives.
    Chitre TS; Asgaonkar KD; Vikhe AB; Patil SM; Garud DR; Khedkar VM; Sarkar D; Nawale LU; Yeware A
    Curr Comput Aided Drug Des; 2021; 17(1):134-143. PubMed ID: 31995017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 8-Alkylmercaptocaffeine derivatives: antioxidant, molecular docking, and in-vitro cytotoxicity studies.
    Sargazi S; Shahraki S; Shahraki O; Zargari F; Sheervalilou R; Maghsoudi S; Soltani Rad MN; Saravani R
    Bioorg Chem; 2021 Jun; 111():104900. PubMed ID: 33894429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives.
    Abhale YK; Sasane AV; Chavan AP; Shekh SH; Deshmukh KK; Bhansali S; Nawale L; Sarkar D; Mhaske PC
    Eur J Med Chem; 2017 May; 132():333-340. PubMed ID: 28411559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives.
    Ghanaat J; Khalilzadeh MA; Zareyee D
    Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS
    Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment.
    Zampieri D; Cateni F; Moneghini M; Zacchigna M; Laurini E; Marson D; De Logu A; Sanna A; Mamolo MG
    Curr Top Med Chem; 2019; 19(8):620-632. PubMed ID: 30827247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
    El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
    Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
    Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents.
    Altimari JM; Hockey SC; Boshoff HI; Sajid A; Henderson LC
    ChemMedChem; 2015 May; 10(5):787-91. PubMed ID: 25788466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies.
    Pisal MM; Nawale LU; Patil MD; Bhansali SG; Gajbhiye JM; Sarkar D; Chavan SP; Borate HB
    Eur J Med Chem; 2017 Feb; 127():459-469. PubMed ID: 28103537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
    Alam MS; Lee DU
    Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.